Sex differences in pharmacological therapy among heart failure patients: A systematic review and meta-analysis

Resource type: Publication Publication
  • Authors
    Danielson C.; Lileikyte G.; Teng T.H.K.; Ouwerkerk W.; Lam C.S.P.; Erlinge D.
  • Type
    Original Research
  • Journal
    European Heart Journal
  • Publication Date
    2020
  • Abstract

    Renin Angiotensin System Inhibitors (RASi) and Beta- Blockers (BB) have been proven effective in trials of heart failure with reduced ejection fraction (HFrEF) in which men were overrepresented. Recent studies have suggested sex differences in pharmacological therapy benefits in HF.We aimed to perform a systematic review and meta-analysis comparing treatment effect among women and men with HFrEF.

Access Publication

Related News